人VEGF165蛋白_ 91517ES

Sku: 91517ES05

尺寸: 2μg
價格:
銷售價格$107.00

已計算運費 結帳時

庫存:
有存貨

描述

VEGF is a potent growth and angiogenic cytokine. It stimulates the proliferation and survival of endothelial cells and promotes angiogenesis and vascular permeability.VEGF is expressed in vascularized tissues and plays an important role in normal and pathological angiogenesis.VEGF has been implicated in tumor metastasis and in the induction of intraocular neovascularization syndromes.VEGF signals through three types of receptors; fms-like tyrosine kinase (flt-1), the KDR gene product (the murine homolog is the flk-1 gene product) and the flt4 gene product. Recombinant Human VEGF165 is a 38.2 kDa, disulfide-linked homodimeric protein consisting of two polypeptide chains of 165 amino acids.

This product, Recombinant Human VEGF165, is supplied as a lyophilized powder with high activity, high purity and low endotoxin.

Specification

Synonyms

Human Vascular Endothelial Growth Factor 165; MVCD1, VAS, vascular endothelial growth factor A, VEGF, VEGFA, VPF

Source

Human VEGF165 Protein is expressed from E.coli without tag.

Ala27-Arg191 with an N-terminal Methionine

Accession

P15692

Molecular Weight

Approximately 38.2 kDa.

AA Sequence

APMAEGGGQNHHEVVKFMDVYQRSYCHPIETLVDIFQEYPDEIEYIFKPSCVPLMRCGGCCNDEGLECVPTEE

SNITMQIMRIKPHQGQHIGEMSFLQHNKCECRPKKDRARQENPCGPCSERRKHLFVQDPQTCKCSCKNTDS

RCKARQLELNERTCRCDKPRR

Endotoxin

< 0.01 EU/μg by the LAL method.

Purity

> 96% by SDS-PAGE and HPLC.

Biological Activity

Fully biologically active when compared to standard. Determined by the dose-dependent stimulation of the proliferation of human umbilical vein endothelial cells (HUVEC) using a concentration range of 1.0-8.0 ng/ml.

Formulation

Lyophilized from a 0.2 µm filtered concentrated solution in PBS, pH 7.4.

Physical Appearance

White lyophilized powder

Storage

-25 ~ -15 ° C storage, valid for 1 year after receipt.

After re-solution, store at 2 ~8 °C, 7 days expiration date. After re-dissolution, store at -85~-65°C, 3 months expiration date.

Compounding Methods

Centrifuge before uncapping to bring contents to the bottom. Use sterile distilled water or PBS to re-dissolve and re-formulate to a concentration of 0.1-1.0 mg/mL, which can be diluted even further according to subsequent experiments; for long-term storage, it is recommended that carrier protein (0.1% BSA) be added to the dilution buffer; dispense for a single experimental dosage, and freeze at -80°C to avoid repeated freezing and thawing.

Cautions

1. Please operate with lab coats and disposable gloves,for your safety.   

2. This product is for research use only.

付款和安全

American Express Apple Pay Diners Club Discover Google Pay Mastercard Visa

您的付款信息已安全處理。我們無法存儲信用卡詳細信息,也無法訪問您的信用卡信息。

詢問

你也可能喜歡

常問問題

本產品僅用於研究目的,不用於人類或動物的治療或診斷用途。產品和內容受以下公司的專利、商標和版權保護: Yeasen 生物技術。商標符號表示原產國,不一定在所有地區註冊。

某些應用程式可能需要額外的第三方智慧財產權。

Yeasen 致力於道德科學,相信我們的研究應該解決關鍵問題,同時確保安全和道德標準。